{"doi":"10.1038/s41375-021-01349-4","title":"Decrease post-transplant relapse using donor-derived expanded NK-cells","abstract":"Abstract In this phase I/II clinical trial, we investigated the safety and efficacy of high doses of mb-IL21 ex vivo expanded donor-derived NK cells to decrease relapse in 25 patients with myeloid malignancies receiving haploidentical stem-cell transplantation (HSCT). Three doses of donor NK cells (1 × 10 5 –1 × 10 8 cells/kg/dose) were administered on days −2, +7, and +28. Results were compared with an independent contemporaneously treated case-matched cohort of 160 patients from the CIBMTR database. After a median follow-up of 24 months, the 2-year relapse rate was 4% vs. 38% ( p = 0.014), and disease-free survival (DFS) was 66% vs. 44% ( p = 0.1) in the cases and controls, respectively. Only one relapse occurred in the study group, in a patient with the high level of donor-specific anti-HLA antibodies (DSA) presented before transplantation. The 2-year relapse and DFS in patients without DSA was 0% vs. 40% and 72% vs. 44%, respectively with HR for DFS in controls of 2.64 ( p = 0.029). NK cells in recipient blood were increased at day +30 in a dose-dependent manner compared with historical controls, and had a proliferating, mature, highly cytotoxic, NKG2C+/KIR+ phenotype. Administration of donor-derived expanded NK cells after haploidentical transplantation was safe, associated with NK cell-dominant immune reconstitution early post-transplant, preserved T-cell reconstitution, and improved relapse and DFS. TRIAL REGISTRATION: NCT01904136 ( https://clinicaltrials.gov/ct2/show/NCT01904136 ).","journal":"Leukemia","year":2021,"id":149598,"datarank":2.495650983066131,"base_score":4.653960350157523,"endowment":4.653960350157523,"self_citation_contribution":0.6980940525236285,"citation_network_contribution":1.7975569305425025,"self_endowment_contribution":0.6980940525236285,"citer_contribution":1.7975569305425025,"corpus_percentile":null,"corpus_rank":null,"citation_count":104,"citer_count":89,"citers_with_citation_signal":65,"citers_with_endowment":65,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9531,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT01904136"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2021-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":636306,"name":"Piyanuch Kongtim","orcid":"0000-0003-2130-7645","position":1,"is_corresponding":false},{"id":637386,"name":"Doris Soebbing","orcid":null,"position":2,"is_corresponding":false},{"id":637387,"name":"Prashant Trikha","orcid":null,"position":3,"is_corresponding":false},{"id":471454,"name":"Gregory K. Behbehani","orcid":"0000-0002-9493-3607","position":4,"is_corresponding":false},{"id":437553,"name":"Gabriela Rondón","orcid":"0000-0003-3841-3567","position":5,"is_corresponding":false},{"id":636307,"name":"Amanda Olson","orcid":"0000-0002-1669-0355","position":6,"is_corresponding":false},{"id":339779,"name":"Qaiser Bashir","orcid":"0000-0002-4086-6453","position":7,"is_corresponding":false},{"id":636308,"name":"Alison Gulbis","orcid":"0000-0003-1921-9152","position":8,"is_corresponding":false},{"id":637388,"name":"Kaur Indreshpal","orcid":null,"position":9,"is_corresponding":false},{"id":18376,"name":"Katayoun Rezvani","orcid":"0000-0002-9599-2246","position":10,"is_corresponding":false},{"id":18375,"name":"Elizabeth J. Shpall","orcid":"0000-0003-3947-4126","position":11,"is_corresponding":false},{"id":58751,"name":"Roland L. Bassett","orcid":"0000-0002-4534-2042","position":12,"is_corresponding":false},{"id":104769,"name":"Kai Cao","orcid":"0000-0002-7939-7279","position":13,"is_corresponding":false},{"id":425172,"name":"Andrew St. Martin","orcid":null,"position":14,"is_corresponding":false},{"id":122963,"name":"Steven M. Devine","orcid":"0000-0001-7731-759X","position":15,"is_corresponding":false},{"id":637389,"name":"Mary Horowitz","orcid":null,"position":16,"is_corresponding":false},{"id":122967,"name":"Marcelo C. Pasquini","orcid":"0000-0003-1579-2293","position":17,"is_corresponding":false},{"id":267502,"name":"Dean A. Lee","orcid":"0000-0001-6693-5392","position":18,"is_corresponding":false},{"id":18374,"name":"Richard E. Champlin","orcid":"0000-0002-4314-5037","position":19,"is_corresponding":false},{"id":313714,"name":"Stefan O. Ciurea","orcid":"0000-0001-8597-3271","position":0,"is_corresponding":true}],"reference_count":23,"raw_metadata":null,"created_at":"2026-07-18T23:42:56.251607Z","pmid":"34312462","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}